Mitsubishi Tanabe, Daiichi Sankyo tie alliance for ALS treatment agent

Mitsubishi Tanabe Pharma Corporation and Daiichi Sankyo Company Limited have announced that they have concluded a licens...

September 18, 2019 | Wednesday | News
Seattle Genetics, Astellas gets USFDA priority review for Enfortumab Vedotin

Seattle Genetics, Inc. and Astellas Pharma Inc. have announced that the U.S. Food and Drug Administration (FDA) has...

September 17, 2019 | Tuesday | News
Astellas, iota Biosciences enter into collaborative R&D agreement

Japanese firm Astellas Pharma and iota Biosciences, Inc. have announced a joint research and development agree...

September 17, 2019 | Tuesday | News
Eisai, Biogen discontinue clinical studies on AD drug candidate

Japan headquartered Eisai Co., Ltd. and US based Biogen Inc. have announced the decision to discontinue the Phase III cl...

September 16, 2019 | Monday | News
Astellas to accelerate early drug discovery

Astellas Venture Management, LLC, a wholly-owned venture capital subsidiary of Japan based Astellas Pharma Inc., and US ...

September 13, 2019 | Friday | News
Chugai Presents Results from Second Positive Global Phase III Clinical Study of Satralizumab

Chugai Pharmaceutical Co., Ltd. (TOKYO:4519) announced that the results from SAkuraStar Study were presented at the...

September 12, 2019 | Thursday | News
Daiichi Sankyo brings new formulation for cancer pain treatment

Daiichi Sankyo Company Limited has announced it has launched a new generic formulation of oxycodone hydrochloride hydrat...

September 12, 2019 | Thursday | News
Daiichi Sankyo Advances [Fam-] Trastuzumab in Japan

 Daiichi Sankyo Company, Limited (hereafter, Daiichi Sankyo) has announced the submission of a New Drug Application...

September 10, 2019 | Tuesday | News
Takeda issues US recall of NATPARA, a parathyroid hormone

Takeda Pharmaceutical Company Limited, on 6 Sep 2019, announced that the company is issuing a US recall for all doses of...

September 9, 2019 | Monday | News
Eisai launches antimicrobial wet wipes

Eisai Co., Ltd. has launched Etak® Antimicrobial Wet Wipes (classified as miscellaneous goods) containing long-...

September 9, 2019 | Monday | News
BNV, Denso establish new medical IoT firm

Beyond Next Ventures Inc. and DENSO Corporation have announced that they have established OPExPARK Inc., a carve-out to ...

September 9, 2019 | Monday | News
Sumitomo Dainippon inks strategic collaboration with Roivant Sciences

Sumitomo Dainippon Pharma Co., Ltd. , a leading Japanese pharmaceutical company, and Roivant Sciences Ltd., a technology...

September 6, 2019 | Friday | News
Sanyo Chemical receives certification for innovative surgical sealant

DEKRA, a European vehicle inspection , has  CE certificate to Japan headquartered Sanyo Chemical Industries fo...

September 6, 2019 | Friday | News
Eisai to develop cognitive function test with Cogstate

Tokyo headquartered Eisai Co., Ltd. has announced that it has entered into a business alliance agreement for exclusive d...

September 5, 2019 | Thursday | News
Japan looks out for rapidly growing ASEAN ageing population

ASEAN is facing rapid population ageing. It is estimated that all ASEAN countries will become ageing society (more than ...

September 4, 2019 | Wednesday | News
Kyowa Kirin gets FDA nod for Parkinson’s drug

Japan headquartered Kyowa Kirin has announced that the U.S. Food and Drug Administration (FDA) has granted approval for ...

September 3, 2019 | Tuesday | News
Invicro Appoints Hidenori Seshimo as Vice President of Biomarker Services, Japan

Invicro , a member of the Konica Minolta Group and a leading provider of biomarkers for imaging, core lab services and s...

August 30, 2019 | Friday | News
Eisai teams up with Merck to tackle NTDs in Kenya

Japan based pharmaceutical firm Eisai Co., Ltd. announced that it provides tanks to supply clean water for the neglected...

August 28, 2019 | Wednesday | News

Podcast

Survey Box

× Please select an option to participate in the poll.
Processing...   View poll results   More polls

× You have successfully cast your vote.
{{ optionDetail.option }}{{ optionDetail.percentage }}%
{{ optionDetail.percentage }}% Complete
More polls